Strategic Global Advisors LLC Takes $1.51 Million Position in Doximity, Inc. (NASDAQ:DOCS)

Strategic Global Advisors LLC bought a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 28,210 shares of the company's stock, valued at approximately $1,506,000.

Other hedge funds have also added to or reduced their stakes in the company. QSV Equity Investors LLC raised its holdings in shares of Doximity by 0.3% in the 4th quarter. QSV Equity Investors LLC now owns 60,763 shares of the company's stock valued at $3,244,000 after purchasing an additional 186 shares during the period. Handelsbanken Fonder AB increased its holdings in shares of Doximity by 0.7% in the fourth quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company's stock valued at $1,586,000 after purchasing an additional 200 shares during the last quarter. UMB Bank n.a. lifted its stake in shares of Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after buying an additional 235 shares during the last quarter. Fielder Capital Group LLC boosted its holdings in shares of Doximity by 4.5% during the 4th quarter. Fielder Capital Group LLC now owns 5,488 shares of the company's stock worth $293,000 after buying an additional 235 shares during the period. Finally, Larson Financial Group LLC raised its holdings in Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock valued at $40,000 after acquiring an additional 250 shares during the period. Institutional investors and hedge funds own 87.19% of the company's stock.

Doximity Price Performance

Doximity stock traded down $0.46 during midday trading on Friday, reaching $50.81. The company's stock had a trading volume of 576,809 shares, compared to its average volume of 2,609,231. The stock has a market capitalization of $9.48 billion, a P/E ratio of 50.83, a PEG ratio of 4.10 and a beta of 1.41. The stock's 50-day simple moving average is $56.56 and its 200-day simple moving average is $58.01. Doximity, Inc. has a 52-week low of $25.00 and a 52-week high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its earnings results on Thursday, May 15th. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.27 by $0.11. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same quarter in the prior year, the firm earned $0.25 earnings per share. The firm's revenue was up 17.1% on a year-over-year basis. As a group, equities research analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the sale, the director now directly owns 16,618 shares in the company, valued at $946,062.74. The trade was a 10.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Anna Bryson sold 45,000 shares of Doximity stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $57.23, for a total value of $2,575,350.00. Following the completion of the transaction, the chief financial officer now owns 357,165 shares of the company's stock, valued at approximately $20,440,552.95. This represents a 11.19% decrease in their position. The disclosure for this sale can be found here. 37.40% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

DOCS has been the topic of several research reports. Truist Financial decreased their price target on shares of Doximity from $58.00 to $52.00 and set a "hold" rating on the stock in a research note on Friday, May 16th. KeyCorp lowered their price objective on shares of Doximity from $83.00 to $70.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Wells Fargo & Company reiterated an "equal weight" rating on shares of Doximity in a report on Friday, February 7th. Leerink Partners upgraded Doximity from a "market perform" rating to an "outperform" rating and raised their price objective for the stock from $60.00 to $90.00 in a research report on Friday, February 7th. Finally, Morgan Stanley lowered their price objective on Doximity from $71.00 to $60.00 and set an "equal weight" rating for the company in a research report on Thursday, April 24th. Eleven analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $61.22.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.